Faculty

Margaret Madeleine

Research Associate Professor, Epidemiology

206-667-4629
mmadelei@uw.edu

Education

PhD Epidemiology, University of Washington, 1996
MPH Epidemiology, Yale University, 1991

Contact

206-667-4629
mmadelei@uw.edu

Fred Hutchinson Cancer Research Center
Box 358080
Epidemiology Program
1100 Fairview Ave N.
Mailstop: M4-C313
Seattle, WA 98109

Bio

Margaret M. Madeleine, MPH, PhD, is a Research Associate Professor in the Department of Epidemiology in the School of Public Health at the University of Washington and an Associate Member of the Program in Epidemiology at the Fred Hutchinson Cancer Research Center. She received her MPH in Epidemiology from Yale in 1991 and PhD from the UW in 1996. She has been a key member of the Seattle HPV research group, and focuses on the epidemiology of HPV related cancers. Prior grants have focused on the role of inflammation and immune genetics in cancer. Current projects focus on the role of HPV vaccination in prevention of HSIL and uptake of HPV vaccination in Washington State.

Research Interests

Dr. Madeleine's major research focus is on the molecular epidemiology of pathogens and our immune response to them that may be associated with cancer development and prognosis. She is interested in the common drivers behind the role that chronic subclinical inflammation (such as occurs with age, viral infection, and UV exposure) plays in cancer. Her current work includes post-licensure trials of the HPV vaccine.

Recent Publications (PubMed)

Application of Statistical Learning to Identify Omicron Mutations in SARS-CoV-2 Viral Genome Sequence Data From Populations in Africa and the United States.
(2022 Sep 1)
JAMA Netw Open 5(9): e2230293
Zhao LP, Lybrand TP, Gilbert P, Madeleine M, Payne TH, Cohen S, Geraghty DE, Jerome KR, Corey L

Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
(2022 Apr 1)
JAMA Dermatol 158(4): 414-425
Sargen MR, Cahoon EK, Yu KJ, Madeleine MM, Zeng Y, Rees JR, Lynch CF, Engels EA

Outcomes of Patients with COVID-19 from a Specialized Cancer Care Emergency Room.
(2022 Jan)
Cancer Invest 40(1): 17-25
Nath SS, Yadav NU, Derkach A, Perez-Johnston R, Tachiki L, Maguire K, Babar A, Maloy MA, Klotz A, Jee J, Taur Y, Chawla S, Babady E, Khaki AR, Madeleine MM, Grivas P, Henning DJ, Aaltonen HL, Lyman GH, Groeger J

Time and geographic variations in human papillomavirus vaccine uptake in Washington state.
(2021 Dec)
Prev Med 153(): 106753
Pourebrahim N, Shah P, VoPham T, Doody DR, Bell TR, deHart MP, Madeleine MM

Barriers to Human Papillomavirus Vaccine Series Completion among Insured Individuals in an Integrated Healthcare Setting.
(2021)
Infect Dis (Auckl) 14(): 11786337211018712
Kamineni A, Blasi PR, Gundersen GD, Oliver M, Dunn JB, Galloway DA, Madeleine MM

Show complete publication list